IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients

Medical Science Monitor

Volumn 7, Issue 5, 2001, Pages 914-918

  Stelmasiak, Zbigniew ^a   Kozioł Montewka, Maria ^a   Dobosz, Beata ^a   Rejdak, Konrad ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CSF; IL 6; Multiple sclerosis; Serum; SIL 6R

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISABILITY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; RATING SCALE;

ADULT; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, INTERLEUKIN-6;

EID: 0034814382     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The cytokine storm in multiple sclerosis
2. Interleukin-6 in biology and medicine
3. Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor
4. On the cellular source and function of IL-6 produced in the CNS in viral diseases
5. Interleukin-6 is elevated in plasma in multiple sclerosis
6. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis
7. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp 130), but not of interleukin-6 are altered in multiple sclerosis
8. Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients
9. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site
10. Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis
11. Interleukin-6 expression in human multiple sclerosis lesions
12. Antibody to IL-6 reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation
13. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
14. IL-6 as an antiinflammatory cytokine; Induction of circulating IL-1 receptor antagonist and soluble and soluble TNF receptor p55